Curaleaf Holdings, Inc. (CURLF) stock
CURLFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$7.63−0.20 (-2.55%)
Close on Oct 19, 2026Market cap $2.07BP/E –Yield –
Curaleaf operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
For fiscal 2025 it was $25.45M, up 2.9% from the year before. The highest annual figure on record is $72.44M in fiscal 2020.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $25.45M | +2.9% |
| FY2024 | Dec 31, 2024 | $24.74M | -42.3% |
| FY2023 | Dec 31, 2023 | $42.88M | -34.0% |
| FY2022 | Dec 31, 2022 | $64.99M | +11.0% |
| FY2021 | Dec 31, 2021 | $58.57M | -19.1% |
| FY2020 | Dec 31, 2020 | $72.44M | – |
| FY2019 | Dec 31, 2019 | -$27.72M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $4.22M | – |
| Q2 FY2025 | Jun 30, 2025 | $6.25M | – |
See a number that looks wrong?